SCHEMBL7982299

SCHEMBL7982299

CCOC(=O)N1CCC(Nc2nc3ccccc3n2Cc2ccoc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
LMNA P02545 2/20 0.53
GAA P10253 2/20 0.53
KDM4E B2RXH2 4/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
MAPT P10636 3/20 0.52
HPGD P15428 2/20 0.52
MAPK1 P28482 2/20 0.52
HSD17B10 Q99714 2/20 0.52
TSHR P16473 1/20 0.52
ATM Q13315 1/20 0.52
NOS2 P35228 2/20 0.48
SSTR5 P35346 4/20 0.48
KCNH2 Q12809 6/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
HTT P42858 2/20 0.46
MLNR O43193 1/20 0.46
CACNA1F O60840 1/20 0.46
EED O75530 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6995354 0.85 LMNA (0.71) ALDH1A1LMNAGAAKDM4ESMN1; SMN2
SCHEMBL9698901 0.85 LMNA (0.73) ALDH1A1LMNAGAAKDM4ESMN1; SMN2
SCHEMBL7492660 0.85 ALDH1A1 (0.53) ALDH1A1LMNAGAAKDM4ESMN1; SMN2
SCHEMBL9687041 0.84 KDM4E (0.52) ALDH1A1LMNAGAAKDM4ESMN1; SMN2
SCHEMBL9698687 0.84 ALDH1A1 (0.53) ALDH1A1LMNAGAAKDM4ESMN1; SMN2
SCHEMBL9629448 0.84 LMNA (0.57) ALDH1A1LMNAGAAKDM4ESMN1; SMN2
SCHEMBL9698262 0.83 SMN1; SMN2 (0.54) ALDH1A1LMNAGAAKDM4ESMN1; SMN2
SCHEMBL6995967 0.82 ALDH1A1 (0.52) ALDH1A1LMNAGAAKDM4ESMN1; SMN2
SCHEMBL9629294 0.82 LMNA (0.67) ALDH1A1LMNAGAAKDM4ESMN1; SMN2
SCHEMBL7970819 0.82 KDM4E (0.51) ALDH1A1LMNAGAAKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211199-B1 HISTAMINE AND TACHYKININ RECEPTOR ANTAGONISTS; ANTIASTHMATICS, ANTIEMETICS; RESPIRATORY SYSTEM DISORDERS, INFLAMMATORY BOWEL DISEASE, CONJUNCTIVITIS AVENTIS PHARMACEUTICALS INC. 2001-04-03 US disclosed
US-RE33833-E Intermediates for antihistamines, antiserotonine agents JANSSEN PHARMACEUTICA N.V. (BE) 1992-02-25 US disclosed
US-4820822-A ANTIHISTAMINE, ANTISEROTONINE AGENTS JANSSEN PHARMACEUTICA (BE) 1989-04-11 US disclosed
US-4760074-A Novel-N-(bicyclic heterocyclyl)-4-piperidinamines JANSSEN PHARMACEUTICA N.V. (BE) 1988-07-26 US disclosed
EP-0099139-B1 NOVEL N-(BICYCLIC HETEROCYCLYL)-4-PIPERIDINAMINES JANSSEN PHARMACEUTICA N.V. (BE) 1987-02-11 EP disclosed
US-4556660-A ANTIALLERGENS JANSSEN PHARMACEUTICA N.V. (BE) 1985-12-03 US disclosed
EP-0099139-A2 Novel N-(bicyclic heterocyclyl)-4-piperidinamines JANSSEN PHARMACEUTICA N.V. (BE) 1984-01-25 EP disclosed